Iliac Artery Stenosis
16
1
3
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.3%
1 terminated out of 16 trials
83.3%
-3.2% vs benchmark
6%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (16)
Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery
Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease
NIRS and Exercise Intensity in Patients With FLIA
A First-in-Man Clinical Trial to Evaluate the Safety and Feasibility of ICS-Elpis in Patients With Iliac Artery Stenosis or Occlusion Lesions
Retrospective Study of the Uni-Graft® K DV Patch in the Clinical Routine
An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow
Evaluation of the Efficacy and Safety of the Application of BeGraft Peripheral Stent Graft System
SOLARIS Peripheral PMCF Trial
BS-CERAB TECHNIQUE
Mesh Stents Study in ILIAC Complex Lesions (IMS-Study)
Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction
Comparison of Aorto-iliac Endovascular Interventions With and Without the EndoNaut Workstation
LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries
Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Stenosis or Occlusion
Safety and Efficacy Study of GoldenFlow Peripheral Stent System
EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries